Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Lungs”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06428422
What this trial is testing

The Impact of Probiotic on Survival and Treatment Response in Metastatic Non-small Cell Lung Cancer Patients

Who this might be right for
Metastatic Non-small Cell Lung Cancer
Necmettin Erbakan University 100
Testing effectiveness (Phase 2)Looking for participantsNCT06472388
What this trial is testing

Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsProgressionNeuroendocrine Tumor Grade 1+4 more
AC Camargo Cancer Center 100
Not applicableNot Yet RecruitingNCT07548788
What this trial is testing

A Lay Navigation Intervention for Patients With Lung Cancer

Who this might be right for
Lung Cancer Non-Small Cell Cancer (NSCLC)Lung Cancer Small Cell Lung Cancer (SCLC)Patient Navigation
University Health Network, Toronto 50
Testing effectiveness (Phase 2)Study completedNCT02336451
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of Oral Ceritinib in Patients With ALK-positive NSCLC Metastatic to the Brain and/or to Leptomeninges

Who this might be right for
ALK-positive Non-small Cell Lung Cancer
Novartis Pharmaceuticals 156
Testing effectiveness (Phase 2)Active Not RecruitingNCT04699188
What this trial is testing

Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

Who this might be right for
KRAS G12C Mutant Solid TumorsCarcinoma, Non-Small-Cell LungCarcinoma, Colorectal+7 more
Novartis Pharmaceuticals 344
Early research (Phase 1)Study completedNCT00923741
What this trial is testing

Effect of Talactoferrin in Adults With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)WithdrawnNCT02763761
What this trial is testing

An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or Opdivo

Who this might be right for
Renal Cell CarcinomaMelanomaLung Cancer
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT03212469
What this trial is testing

A Trial of Durvalumab and Tremelimumab in Combination With SBRT in Patients With Metastatic Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaLung CancerOesophageal Cancer
Gustave Roussy, Cancer Campus, Grand Paris 54
Testing effectiveness (Phase 2)Looking for participantsNCT07586202
What this trial is testing

Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLC 68
Testing effectiveness (Phase 2)Ended earlyNCT03325166
What this trial is testing

Pembrolizumab and Magnetic Resonance Imaging With Ferumoxytol in Treating Patients With Non-small Cell Lung Cancer and Brain Metastases

Who this might be right for
Lung Carcinoma Metastatic in the BrainStage IV Lung Non-Small Cell Cancer AJCC v7
OHSU Knight Cancer Institute 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT05013450
What this trial is testing

Dupilumab_Metastatic NSCLC

Who this might be right for
Metastatic Non-small Cell Lung Cancer
Thomas Marron 33
Testing effectiveness (Phase 2)Study completedNCT00297089
What this trial is testing

A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerNSCLCNon-Small-Cell Lung Cancer
AbbVie (prior sponsor, Abbott) 165
Testing effectiveness (Phase 2)Ended earlyNCT01210378
What this trial is testing

Nitroglycerin in Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
Maastricht Radiation Oncology 47
Very early researchStudy completedNCT04267874
What this trial is testing

Black Raspberry Nectar for the Prevention of Lung Cancer, BE WELL Study

Who this might be right for
Lung CarcinomaTobacco-Related Carcinoma
Ohio State University Comprehensive Cancer Center 96
Testing effectiveness (Phase 2)Ended earlyNCT00034697
What this trial is testing

Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143)

Who this might be right for
Metastases, NeoplasmCarcinoma, Non-Small-Cell LungBrain Neoplasms
Merck Sharp & Dohme LLC 24
Testing effectiveness (Phase 2)UnknownNCT00270582
What this trial is testing

Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small-Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Far Eastern Memorial Hospital 58
Testing effectiveness (Phase 2)UnknownNCT05284994
What this trial is testing

TQ-B3525 Tablets Combined With Osimertinib Mesylate Tablets in the Treatment of Advanced Non-Small Cell Lung Cancer

Who this might be right for
Nonsmall-cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 160
Very early researchLooking for participantsNCT07235280
What this trial is testing

Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma

Who this might be right for
Lung AdenocarcinomaStage IA1 Lung Cancer American Joint Committee on Cancer (AJCC) v8Stage IA2 Lung Cancer AJCC v8+2 more
Jonsson Comprehensive Cancer Center 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07827261
What this trial is testing

BL-B01D1 Combined With Glecirasib in Patients With KRAS G12C-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 36
Testing effectiveness (Phase 2)Looking for participantsNCT06147570
What this trial is testing

HS-10365 in Patients With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

Who this might be right for
Nonsmall Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd. 62
Next Page